產品中心Cell Resources
聯系我們CONTACT US
400-999-210024小時服務熱線
產品概述
產品簡介
RPMI-1640是Moore等人于1967年在美國紐約州法羅市的羅斯韋爾公園紀念研究所(Roswell Park Memorial Institute，RPMI)開發(fā)出來的，RPMI是該研究所開發(fā)的一類細胞培養(yǎng)基，1640是培養(yǎng)基代號。RPMI-1640是改進型的McCoy's 5A培養(yǎng)基，使用碳酸氫鹽緩沖系統(tǒng)，與大多數哺乳動物細胞培養(yǎng)基不同的是其典型的PH8的配方。RPMI-1640培養(yǎng)基最初是為淋巴細胞培養(yǎng)專門設計的，現在已廣泛應用于各種正常細胞和癌細胞的培養(yǎng)，尤其是懸浮細胞的培養(yǎng)，是使用最為廣泛的培養(yǎng)基之一。
產品說明
| 產品形態(tài) | 液體 |
| 產品濃度 | 1× |
| 產品規(guī)格 | 125mL×4 |
| 培養(yǎng)基成分 | RPMI-1640(PM150110)＋10% FBS(164210-50)＋1% P/S(PB180120)＋1% GlutaMax(PB180419) |
| 細菌檢測 | 陰性 |
| 真菌檢測 | 陰性 |
| 支原體檢測 | 陰性 |
| 細胞生長實驗 | 細胞生長良好，形態(tài)正常 |
| 內毒素含量(EU/mL) | ≤3 |
| 儲存條件 | 2-8℃，避光儲存 |
| 運輸條件 | 冰袋冷藏運輸 |
| 有效期 | 6個月 |
注意事項
1、使用產品時應注意無菌操作，避免污染。 2、本產品含有血清和雙抗，如無特別需要不用額外再添加血清和雙抗，可以直接使用。 3、為保持本產品的最佳使用效果，不宜將其長時間放置于室溫或較高的溫度環(huán)境中。 4、所有產品請于保質期內使用，超出保質期，必須放棄使用。 5、本產品只供進一步科研使用，不可應用于臨床等其他方面。
參考文獻
-
Dual-inhibition of lactate metabolism and Prussian blue-mediated radicals generation for enhanced chemodynamic therapy and antimetastatic effect(2023/04/18)
作者：Wenting Li, Shikai Liu, Yangyang Zhang
期刊：Nanoscale
影響因子 ：6.700
-
The Scutellaria-Coptis herb couple and its active small-molecule ingredient wogonoside alleviate cytokine storm by regulating the CD39/NLRP3/GSDMD signaling pathway(2024/04/07)
作者：Huan Wang, Yuejia Lan, Liuling Luo
期刊：JOURNAL OF ETHNOPHARMACOLOGY
影響因子 ：5.400
引用產品：PM150110B
-
ADMSC Exo-MicroRNA-22 improve neurological function and neuroinflammation in mice with Alzheimers disease(2021/07/26)
作者：Liping Zhai, Heping Shen, Yongjia Sheng
期刊：Journal Of Cellular And Molecular Medicine
影響因子 ：5.300
引用產品：PM150110B
-
Artesunate-loaded solid lipid nanoparticles resist esophageal squamous cell carcinoma by inducing Ferroptosis through inhibiting the AKT/mTOR signaling(2024/02/16)
作者：Yu Xia, Yixin Tang, Zhixin Huang
期刊：CELLULAR SIGNALLING
DOI：10.1016/j.cellsig.2024.111108
影響因子 ：4.800
引用產品：PM150110B
-
A pH-responsive organic photosensitizer specifically activated by cancer lysosomes(2018/04/08)
作者：Fengfeng Xue, Peng Wei, Xiaoting Ge
期刊：Dyes And Pigments
DOI：10.1016/j.dyepig.2018.04.008
影響因子 ：4.500
引用產品：PM150110B
-
Oral Cancer Stem Cell-Derived Small Extracellular Vesicles Promote M2 Macrophage Polarization and Suppress CD4+ T-Cell Activity by Transferring UCA1 and Targeting LAMC2(2022/11/28)
作者：Lan Wu, Sai Ye, Yilin Yao, Chenping Zhang, Wei Liu
期刊：Stem Cells International
影響因子 ：4.300
-
MicroRNA‐329‐mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma(2018/12/23)
作者：Zhigao Hu, Chaowen Zheng, Huizhao Su
期刊：Journal Of Cellular Biochemistry
影響因子 ：4.000
引用產品：PM150110B
-
Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells(2023/11/13)
作者：Huan He, Shaozheng Wang, Wen Zhang
期刊：BMC CANCER
DOI：10.1186/s12885-023-11552-4
影響因子 ：3.800
引用產品：PM150110B
-
Role and mechanism of COL3A1 in regulating the growth, metastasis, and drug sensitivity in cisplatin-resistant non-small cell lung cancer cells(2024/03/26)
作者：Jiankun Ren, Songwei Zhao, Junyu Lai
期刊：CANCER BIOLOGY & THERAPY
DOI：10.1080/15384047.2024.2328382
影響因子 ：3.600
引用產品：PM150110B
-
Exosomal transfer of activated neutrophil-derived lncRNA CRNDE promotes proliferation and migration of airway smooth muscle cells in asthma(2021/09/30)
作者：Xiaoyu Zhang, Zhuochang Chen, Nan Li
期刊：Human Molecular Genetics
影響因子 ：3.500
-
The combination of SHOX2 and RASSF1A DNA methylation had a diagnostic value in pulmonary nodules and early lung cancer(2024/01/23)
作者：Bin Xie, Wenyan Dong, Fengping He
期刊：ONCOLOGY
影響因子 ：3.500
引用產品：PM150110B
-
Long non?coding RNA HCG18 facilitates the progression of laryngeal and hypopharyngeal squamous cell carcinoma by upregulating FGFR1 via miR?133b(2021/12/08)
作者：Hongbin Peng, Pingjiang Ge
期刊：Molecular Medicine Reports
影響因子 ：3.400
-
LINC00261 Inhibits Esophageal Cancer Radioresistance by Down-Regulating microRNA-552-3p and Promoting DIRAS1(2021/11/13)
作者：Baolong Yang, Hongbing Ma, Yan Bian
期刊：Cancer Management and Research
影響因子 ：3.300
引用產品：PM150110B
-
Decreasing REDD1 expression protects against high glucose-induced apoptosis, oxidative stress and inflammatory injury in podocytes through regulation of the AKT/GSK-3β/Nrf2 pathway(2023/02/22)
作者：Xiaojing Wang, Jing Yang, Wenxing Wang
期刊：IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
DOI：10.1080/08923973.2023.2183351
影響因子 ：3.300
引用產品：PM150110B
-
Circ_0003159 upregulates LIFR expression through competitively binding to miR-221-3p/miR-222-3p to block gastric cancer development(2022/01/16)
作者：Liansheng Zheng,?Boshi Yan,?Guoliang Jin
期刊：Journal Of Molecular Histology
DOI：10.1007/s10735-021-10044-8
影響因子 ：3.200
-
Hsa_circ_0051908 Promotes Hepatocellular Carcinoma Progression by Regulating the Epithelial–Mesenchymal Transition Process(2024/04/30)
作者：Yinbing Wu, Huafei Tang, Shuzhong Cui
期刊：Analytical Cellular Pathology
影響因子 ：3.200
引用產品：PM150110B
-
Neferine inhibits the progression of diabetic nephropathy by modulating the miR-17-5p/nuclear factor E2-related factor 2 axis(2023/12/04)
作者：Hongmei Huang, Maojun Yang, Ting Li
期刊：Journal of Traditional Chinese Medicine
DOI：10.19852/j.cnki.jtcm.20231204.004
影響因子 ：2.600
引用產品：PM150110B
-
LncRNA NEAT1 Knockdown Alleviates Lipopolysaccharide-Induced Acute Lung Injury by Modulation of miR-182-5p/WISP1 Axis(2021/05/27)
作者：Sensen Lv, Xiaolu Qu, Yan Qu
期刊：Biochemical Genetics
DOI：10.1007/s10528-021-10081-8
影響因子 ：2.400
-
Circ_0044516 Enriches the Level of SARM1 as a miR-330-5p Sponge to Regulate Cell Malignant Behaviors and Tumorigenesis of Prostate Cancer(2022/01/07)
作者：Yan Wu
期刊：Biochemical Genetics
DOI：10.1007/s10528-021-10160-w
影響因子 ：2.400
-
CircFBXW8 Acts an Oncogenic Role in the Malignant Progression of Non-small Cell Lung Carcinoma by miR-370-3p-Dependent Regulation of TRIM44(2022/01/06)
作者：Xia Wang?,?Jian Lv?,?Bin He?
期刊：Biochemical Genetics
DOI：10.1007/s10528-021-10177-1
影響因子 ：2.400
-
Circ_0007031 Silencing Inhibits Cell Proliferation and Induces Cell Apoptosis via Downregulating MELK at a miR-485-3p-Dependent Way in Colorectal Cancer(2021/7/28)
作者：Shengtian Su, Wenjing Lu, Jun Liu
期刊：Biochemical Genetics
DOI：10.1007/s10528-021-10111-5
影響因子 ：2.400
-
CCT6A promotes esophageal squamous cell carcinoma cell proliferation, invasion and epithelial-mesenchymal transition by activating TGF-β/Smad/c-Myc pathway(2023/04/05)
作者：Xiuli Xia, Shushan Zhao, Wenting Chen
期刊：IRISH JOURNAL OF MEDICAL SCIENCE
DOI：10.1007/s11845-023-03357-y
影響因子 ：2.100
-
The antitumor activity and pharmacokinetics research of PPD-Arg (Tos) using ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry(2022/10/26)
作者：Jiayin Liu, Yang An, Jun Su
期刊：BIOMEDICAL CHROMATOGRAPHY
DOI：10.1002/bmc.5535
影響因子 ：1.911
引用產品：PM150110B
-
Exosomes Promote Atherosclerosis Progression by Regulating Circ_100696/miR-503-5p/PAPPA Axis-Mediated Vascular Smooth Muscle Cells Proliferation and Migration(2023/09/30)
作者：Jing Liu, Xiangyang Zhang, Zhaoxia Yu
期刊：International Heart Journal
影響因子 ：1.500
-
BIOINFORMATIC ANALYSIS OF DOSE- AND TIME-DEPENDENT miRNome RESPONSES(2019/5/1)
作者：G Babini, B Tanno, I De Stefano
期刊：Radiation Protection Dosimetry
影響因子 ：1.000
引用產品：PM150110B
-
Network pharmacology and in vitro studies reveal the pharmacological effects and molecular mechanisms of Shenzhi Jiannao prescription against vascular dementia(2022/02/02)
作者：Danfeng Tian, Qiang Gao, Ze Chang
期刊：BMC Complementary and Alternative Medicine
DOI：10.1186/s12906-021-03465-1
影響因子 ：0.000
引用產品：PM150110B
FAQs
Q：{{item.question}}
A：
產品資料
識別碼示意圖
